Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Poll: By a 2-to-1 margin, Americans say Trump has done more to raise prices than lower them - 2Israel violated ceasefire with Hezbollah more than 10,000 times, UNIFIL claims
- 3Shredded cheese recall: Multiple brands sold at Aldi, Target and Walmart affected over potential metal fragment contamination
- 4Figure out What Shift Differentials Mean for Your General Attendant Compensation
- 5The pace of hiring just fell to the lowest since 2011, outside of the pandemic
- 'The Drama' plot twist, explained: What did Zendaya's character do, and what happens to her wedding?
- Clones of Stumpy, Washington D.C.'s beloved cherry blossom tree, have flowered for the first time
- 80 km. on foot: Sharren Haskel’s three-day march in protest of haredi draft bill
- What's The Friendliest City In The United Kingdom?
- 9 African migrants died in freezing temperatures near Morocco-Algeria border
- Drenched in Pixels: A Survey of \Vivid Interactivity Experience\ Game
- Disney's latest short film 'Versa' tackles a difficult subject: Pregnancy loss. It's resonating with viewers.
- Mexico says a third of 130,000 missing people might be alive, fueling criticism from families
- See tonight’s solar storm unfold across the world
